Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study

Ann Hematol. 2012 Feb;91(2):203-13. doi: 10.1007/s00277-011-1286-0. Epub 2011 Jul 9.

Abstract

Isochromosome of the long arm of chromosome 20 with interstitial loss of material [ider(20q)] is a rare cytogenetic abnormality reported in myelodysplastic syndrome (MDS), with neither specific morphological pattern nor clear prognostic significance. The aim of this retrospective multicentric study is to compare the peripheral blood and bone marrow morphology of MDS patients with ider(20q) (n = 13) and del(20q) (n = 21) and controls (n = 47) in order to investigate whether the ider(20q) harbors specific morphological features. The secondary objective is to compare the outcome of patients from both groups. This study performed on the largest cohort of MDS patients with ider(20q) is the first that identifies specific morphological features (hypogranulated and vacuolized neutrophils and neutrophil erythrophagocytosis) allowing the identification of this cytogenetic abnormality with high sensitivity (70%) and specificity (85.7%). Suspected ider(20q) by morphology should therefore support targeted FISH tests in case of non informative karyotype. This combined approach will allow a better estimation of the prevalence of this underdiagnozed entity. The overall survival and progression-free survival did not statistically differ in both groups. However, hypogranulated and vacuolized neutrophils were significantly associated with survival.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Cells* / cytology
  • Blood Cells* / physiology
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / physiology
  • Chromosome Aberrations*
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 20 / genetics
  • Cohort Studies
  • Cytogenetics / methods*
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Isochromosomes / genetics
  • Karyotype
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / mortality*
  • Retrospective Studies
  • Sensitivity and Specificity